In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs Prices Control Order,

jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la- 2767] ubZ fnYyh] 'kqØokj] vxLr 23] 2019@Hkkæ 1] 1941 No. 2767] NEW DELHI, FRIDAY, AUGUST 23, 2019/BHADRA 1, 1941 jjjjllllkkkk;;;;uuuu vvvvkkkkSSjjSSjj mmmmooooZjZjZjZjdddd eeeea=a=a=a=kkkkyyyy;;;; ¼¼¼¼vvvvkkkk""SS""SSkkkk////kkkk ffffooooHHHHkkkkkkkkxxxx½½½½ ¼¼¼¼jjjjkkkk""""VVVVªªhhªªhh;;;; vvvvkkkk""SS""SSkkkk////kkkk eeeeYYwwYYww ;;;; ffffuuuu////kkkkkkkkZjZjZjZj....kkkk iiiizkzkzkzkffff////kkkkddddjjjj....kkkk½½½½ vvvvkkkknnnn’’ss’’ss kkkk ub Z fnYyh] 23 vxLr] 2019 ddddkkkk----vvvvkkkk---- 3333000033332222¼¼¼¼vvvv½½½½.—Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 eb]Z 2013 vkjS dk-vk- 701¼v½ rkjh[k 10 ekp]Z 2016 d s lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk inz Rr 'kfDr;k sa dk iz;kxs djr s gq,] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k ¼ftldk s lfa{kIr :i e sa ,uihih, dgk tkrk gS½] uhp s dh lkj.kh d s LrHak ¼6½ e as fofufn"ZV [knq jk eYw ; dk s mDr lkj.kh d s LrHak ¼3½] ¼4½] vkSj ¼5½ e as rRLFkkuh ifzof"V;k sa e sa fofufn"ZV izcyrk] bdkb Z ¼;fwuV½ vkSj fofuekZrk vkSj foi.ku dEifu;k sa d s uke lfgr LrHak ¼2½ e sa dh rRLFkkuh ifzof"V e sa l s iRz;ds dh] oLr q ,o a lsok dj] ;fn dksb Z gS] dk s NksMd+ j vf/kdre [knq jk eYw ; d s :i e sa fu;r djrh gSA llllkkkkjjjj....kkkkhhhh Ø-l-a vuqlfwpr fofufefZr dk icz yrk bdkb Z fofuekZrk vkjS foi.ku dia uh [knq jk uke@czkMa dk uke eYw ; ¼#-½ (1) (2) (3) (4) (5) (6) 1. ,eVªhflVkckbu $ iRz;ds fQYe fyfir xkys h e%sa 1 xkys h 51.34 Vus kQs ksohj xkys h ,eVªhflVkckbu vkbiZ h 200 fexzk-] eSll Z gVs sjk s ycs fy-@eSll Z Vus kQs ksohj ,yQs us kekbM ges hQeq kjVs d s cjkcj Vus kQs ksohj ,eD;jw s QkekZL;fwVdYl fy- ,yQs us kekbM 25 fexzk- 2. Mkys Vq xs zsohj iRz;ds fQYe fyfir xkys h e%sa 1 xkys h 130.61 $,eVªhflVkckbu $ Mkys Vq xs zsohj lkfsM;e d s cjkcj Mkys Vq sxzsohj 50 fexzk-] Vus kQs ksohj ,yQs us kekbM eSll Z ,eD;jw s QkekZL;fwVdYl ,eVªhflVkckbu vkbiZ h 200 fexzk-] xkys h fy- Vus kQs ksohj ,yQs us kekbM Qeq kjVs d s cjkcj Vus kQs ksohj ,yQs us kekbM 25 fexzk- 4345 GI/2019 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] uuuukkkkVVssVVss %%%% ¼d½ mi;qZDr nh xb Z fofufn"ZV QkWeywZ s'ku d s fofuekZrk vFkkZr tk s Þub Z Mªxß Mhihlhvk]s 2013 d s iSjkxzkQ 2¼;½w d s rgr mi;qZDr nh xb Z lkj.kh d s LrHak ¼6½ e sa fofufn"ZV [knq jk eYw ; fu/kkfZjr djxsa As ¼[k½ vxj fuekZrkvk sa u s mi;qDZ r lkj.kh d s LrHak (6) e sa of.kZr vf/kdre dher ij ljdkj dk s okLro e sa Hkxq rku fd;k gS ;k ;g n;s gS rk s o s oLr q ,o a lsok dj dk s tkMs + ldr s gSAa ¼x½ vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 11 e sa fn, x, izko/kkuk sa d s rgr fuekZrkvk sa dk s mi;qDZ r lkj.kh d s LrHak ¼6½ e sa fofufn"ZV [knq jk eYw ; d s vk/kkj ij vuqlfwpr fofufefZr;k sa d s iSdksa d s fy, [knq jk eYw ; fu/kkfZjr djsaA fuekZrk vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 24 d s rgr QkWe Z V e sa vf/klpw uk dh rkjh[k l s ,d eYw ; lpw h ,uihih, dk s vkbZihMh,e,l d s ek/;e l s tkjh dj sa rFkk mldh dkiWh jkT; vkS"kf/k fu;a=dk sa vkSj fofuekZrk forjdk sa dk s tkjh djAsa ¼?k½ vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s 24 (4) d s mic/akk sa d s vuqlkj iRz;ds QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i e sa ,sl s ifjlj] tgk a dkjckj dk s bl idz kj fd;k tk jgk gS fd mll s ijke’k Z d s bPNdq fdlh O;fDr d s fy, igpqa vklku gk]s ogk a mld s fdlh lgtn’` ; Hkkx ij dher lpw h vkSj iwjd lpw h] ;fn dkbs Z gk]s dk s lainz f’kZr djxs kA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[knq jk eYw ;½ dsoy mi;qZDr fuekZrk@foi.ku d s fy, ykx w gS tSlk fd mUgkusa s vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s rgr vuqc) eYw ; fu/kkZj.k@la'kk/sku d s fy, QkWe Z I ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkfZjr lHkh ykx w oS/kkfud vko';drkvk sa dh ifwr Z d s v/khu izklfaxd fof/k;ksa@fu;ek sa d s vUrxZr tSlk fd dUsnzh;@jkT; ykblfslxa vkWFkkfsjVh d s l{ke izkf/kdkjh }kjk eUs;wQsDpfjxa ykblsal eta wjh d s rgr lca fa/kr fofufeZr fuekZrk@foi.ku dEifu;k a tk s vuqikyu djrh gSA ¼p½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufefZr;k sa vkSj fofufn"ZV 'krks± dk ikyu ugh a djrh gS a rk s o s vko';d oLrq,¡ vf/kfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk sa d s v/khu C;kt lfgr vf/kiHzkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxsa As ¼N½ bl vkn's k e sa mijkDs r lkj.kh d s LrHak ¼2½ e sa dh rRLFkkuh ifzof"V e sa fofufn"ZV fofufefZr;k sa d s iSdk sa dh [knq jk eYw ; fu;r gkus s d s ifj.kkeLo:i] vkn's k tk s fd bl vkn's k l s iow Z tkjh g,q gS] Lor% gh fujLr gk s tk;xsa As [dk-a l-a@201@69@2019@,Q@Qk- l-a 8¼69½@2019@Mhih@,uihih,&fMoh-&II] izlus thr nkl] lgk;d fun's kd MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 23rd August, 2019 S.O. 3032(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE Sl. Name of the Strength Unit Manufacturer & Retail No. Formulation/ Marketing Company Price Brand Name (Rs.) (1) (2) (3) (4) (5) (6) 1. Emtricitabine + Each film coated tablet contains: 51.34 M/s Hetero Labs Ltd. / Tenofovir Tablet Emtricitabine IP 200mg. 1 Tablet M/s Emcure Tenofovir Alafenamide Hemifumarate Pharmaceuticals Ltd. eq. to Tenofovir Alafenamide 25mg¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3 2. Dolutegravir + Each film coated tablet contains: 130.61 Emtricitabine + Dolutegravir Sodium eq. to M/s Emcure Tenofovir Dolutegravir 50mg, 1 Tablet Pharmaceuticals Alafenamide Tablet Emtricitabine IP 200mg, Limited Tenofovir Alafenamide Fumarate eq. to Tenofovir Alafenamide 25mg. Note: (a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [P.N./201/69/2019/F/F. No. 8(69)/2019/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.